A Message from the Dean
Made For TV
Law School is One-Stop Shop for Clerkships
In Career-Defining Case, Adelman Put Hinckley away
At Reunion, Sadler Flashes Back 40 Years
The Brief
Graduation/Reunion
The Board of Overseers
Faculty News & Publications
Philanthropy
Alumni Briefs
In Memoriam
Case Closed
 
SYLLABUS
New Course on the FDA Will Tackle Controversial Regulatory Issues
1 - 2 - 3

 
FEATURED STORIES
MEDIA HIGHLIGHTS
PRINT
BROADCAST
Assistant Professor Ted Ruger usually teaches Constitutional History and Law. But in the new course he’s designing for this fall, Ruger and his students will be studying a field of the law where history is written not in textbooks, but in the week’s headlines.

“What’s exciting about this new course on the Food and Drug Administration is that the issues being debated in the here and now have real policy implications,” Ruger says. Those issues include the cost of prescription drugs, the safety of unregulated vitamins and supplements, fee-based drug approval expediting, and, after recent deaths related to VIOXX and other NSAID pain-relievers, concerns about the approval of unsafe drugs.
 
Previous Page Next Page